Safety and tolerability of Pau d' Arco (Tabebuia avellanedae) for primary dysmenorrhea: A single-arm, open-label trial on adults ages 18-45.
Adv Integr Med
; 9(3): 159-166, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-36960315
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Aspects:
Patient_preference
Language:
En
Journal:
Adv Integr Med
Year:
2022
Document type:
Article
Affiliation country: